Furthermore, we explored the crosstalk between TP53 high/low score tumor cells and immune cells (T and NK cells) by analyzing published BLCA single-cell RNA-sequencing (scRNA-seq) data. This evidence concerns the gene TP53 and bladder transitional cell carcinoma.